PT Victoria Care Indonesia Tbk
IDR 985-IDR 70 (-6.64%)
PT Victoria Care Indonesia Tbk’s quoted price sits in the upper half of its reported 52-week range, 31.83% below the high.
JKT · DAYA.JK · IDR
Stock price, earnings
Quote as of Oct 30, 2026, 09:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · IDR. Historical prices are not a forecast.
PT Duta Intidaya Tbk’s quoted price sits in the lower half of its reported 52-week range, 37.66% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow PT Duta Intidaya Tbk’s reporting calendar.
THE COMPANY BEHIND THE TICKER
PT Duta Intidaya Tbk operates as a prominent health and beauty retailer throughout Indonesia, offering a diverse product portfolio. Its offerings span pharmaceutical products, including medicines and various pharmacy goods, alongside medical and wellness devices. The company also supplies personal care and skincare items, fragrances, cosmetics, infant products, and a selection of general merchandise. Furthermore, it engages in the trade of food and beverage items. Beyond its retail activities, PT Duta Intidaya Tbk undertakes various roles within the supply chain, serving as an agent, sole representative, distributor, purveyor, franchisor, and supplier for a wide array of traded goods. As of December 31, 2021, the company maintained a significant physical presence with 160 Watsons-branded stores spread across 14 provinces. Its digital reach is extensive, providing products through major e-commerce platforms like Shopee.com, Tokopedia.com, Lazada.com, Blibli.com, and Bukalapak.com, as well as via applications such as Halodoc, Bima+, Good Doctor, GrabMart, and GoMart. Established in 2005 and headquartered in South Jakarta, Indonesia, the company is a subsidiary of Total Alliance Holdings Limited.
Latest available per-share figures in IDR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
IDR 985-IDR 70 (-6.64%)
PT Victoria Care Indonesia Tbk’s quoted price sits in the upper half of its reported 52-week range, 31.83% below the high.
IDR 191+IDR 1 (+0.53%)
Medela Potentia Tbk.’s quoted price sits in the lower half of its reported 52-week range, 36.33% below the high.
IDR 338-IDR 20 (-5.59%)
PT Kimia Farma (Persero) Tbk’s quoted price sits in the lower half of its reported 52-week range, 56.94% below the high.
IDR 1,570IDR 0 (0.0%)
PT Darya-Varia Laboratoria Tbk’s quoted price sits in the upper half of its reported 52-week range, 7.37% below the high.
IDR 2,470+IDR 20 (+0.82%)
PT. Mandom Indonesia Tbk’s quoted price sits in the lower half of its reported 52-week range, 34.83% below the high.
IDR 486+IDR 28 (+6.11%)
PT Multi Indocitra Tbk’s quoted price sits in the lower half of its reported 52-week range, 33.42% below the high.
IDR 198IDR 0 (0.0%)
PT Millennium Pharmacon International Tbk’s quoted price sits in the upper half of its reported 52-week range, 13.16% below the high.
IDR 254IDR 0 (0.0%)
PT Phapros, Tbk’s quoted price sits in the lower half of its reported 52-week range, 44.78% below the high.